A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting
- Author
- HUSSAIN, S. A1 2 ; PALMER, D. H1 2 ; CHETIYAWARDANA, A. D2 ; CULLEN, M. H2 ; SWINSON, D. E2 ; RILEY, P2 ; WILLS, A2 ; BROWN, C2 ; DRAYCOTT, C2 ; EL-MODIR, A2 ; PEAKE, D. R2 ; REA, D. W1 2
[1] Cancer Research UK Institute for Cancer Studies, University of Birmingham, United Kingdom
[2] University Hospital Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TT, United Kingdom - Source
Oncology reports. 2008, Vol 20, Num 1, pp 233-237, 5 p ; ref : 17 ref
- ISSN
- 1021-335X
- Scientific domain
- Medical oncology
- Publisher
- [S.n.], Athens
- Publication country
- Greece
- Document type
- Article
- Language
- English
- Author keyword
- gemcitabine lung cancer outpatient chemotherapy phase II clinical trial split cisplatin
- Keyword (fr)
- Ambulatoire Anticancéreux Cancer du poumon Cancérologie Carcinome non petite cellule bronchopulmonaire Chimiothérapie Cisplatine Dose Essai clinique phase II Gemcitabine Stade avancé Traitement Agent alkylant Antimétabolite Cancer Dérivé de la pyrimidine Fluor Composé organique Pathologie de l'appareil respiratoire Pathologie des bronches Pathologie des poumons Platine II Complexe Pyrimidine nucléoside Tumeur maligne
- Keyword (en)
- Ambulatory Antineoplastic agent Lung cancer Cancerology non-small cell lung carcinoma Chemotherapy Cisplatin Dose Phase II trial Gemcitabine Advanced stage Treatment Alkylating agent Antimetabolic Cancer Pyrimidine derivatives Fluorine Organic compounds Respiratory disease Bronchus disease Lung disease Platinum II Complexes Pyrimidine nucleoside Malignant tumor
- Keyword (es)
- Ambulatorio Anticanceroso Cáncer del pulmón Cancerología Carcinoma no pequeňa célula bronchopulmonar Quimioterapia Cisplatino Dosis Ensayo clínico fase II Gemcitabina Estadio avanzado Tratamiento Agente alquilante Antimetabólito Cáncer Pirimidina derivado Fluor Compuesto orgánico Aparato respiratorio patología Bronquio patología Pulmón patología Platino II Complejo Pirimidina nucleósido Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum
- Discipline
- Pulmonology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20474417
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting\";s:9:\"\u0000*\u0000jtitle\";s:16:\"Oncology reports\";s:9:\"\u0000*\u0000stitle\";s:10:\"Oncol. rep\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"233\";s:8:\"\u0000*\u0000epage\";s:3:\"237\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1021-335X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HUSSAIN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"PALMER, D. H\";i:1;s:20:\"CHETIYAWARDANA, A. D\";i:2;s:12:\"CULLEN, M. H\";i:3;s:13:\"SWINSON, D. E\";i:4;s:8:\"RILEY, P\";i:5;s:8:\"WILLS, A\";i:6;s:8:\"BROWN, C\";i:7;s:11:\"DRAYCOTT, C\";i:8;s:11:\"EL-MODIR, A\";i:9;s:11:\"PEAKE, D. R\";i:10;s:9:\"REA, D. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:6:\"[S.n.]\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting\";s:9:\"\u0000*\u0000jtitle\";s:16:\"Oncology reports\";s:9:\"\u0000*\u0000stitle\";s:10:\"Oncol. rep\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"233\";s:8:\"\u0000*\u0000epage\";s:3:\"237\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1021-335X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HUSSAIN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"PALMER, D. H\";i:1;s:20:\"CHETIYAWARDANA, A. D\";i:2;s:12:\"CULLEN, M. H\";i:3;s:13:\"SWINSON, D. E\";i:4;s:8:\"RILEY, P\";i:5;s:8:\"WILLS, A\";i:6;s:8:\"BROWN, C\";i:7;s:11:\"DRAYCOTT, C\";i:8;s:11:\"EL-MODIR, A\";i:9;s:11:\"PEAKE, D. R\";i:10;s:9:\"REA, D. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:6:\"[S.n.]\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting\";s:9:\"\u0000*\u0000jtitle\";s:16:\"Oncology reports\";s:9:\"\u0000*\u0000stitle\";s:10:\"Oncol. rep\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"233\";s:8:\"\u0000*\u0000epage\";s:3:\"237\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1021-335X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HUSSAIN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"PALMER, D. H\";i:1;s:20:\"CHETIYAWARDANA, A. D\";i:2;s:12:\"CULLEN, M. H\";i:3;s:13:\"SWINSON, D. E\";i:4;s:8:\"RILEY, P\";i:5;s:8:\"WILLS, A\";i:6;s:8:\"BROWN, C\";i:7;s:11:\"DRAYCOTT, C\";i:8;s:11:\"EL-MODIR, A\";i:9;s:11:\"PEAKE, D. R\";i:10;s:9:\"REA, D. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:6:\"[S.n.]\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting\";s:9:\"\u0000*\u0000jtitle\";s:16:\"Oncology reports\";s:9:\"\u0000*\u0000stitle\";s:10:\"Oncol. rep\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"233\";s:8:\"\u0000*\u0000epage\";s:3:\"237\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1021-335X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HUSSAIN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"PALMER, D. H\";i:1;s:20:\"CHETIYAWARDANA, A. D\";i:2;s:12:\"CULLEN, M. H\";i:3;s:13:\"SWINSON, D. E\";i:4;s:8:\"RILEY, P\";i:5;s:8:\"WILLS, A\";i:6;s:8:\"BROWN, C\";i:7;s:11:\"DRAYCOTT, C\";i:8;s:11:\"EL-MODIR, A\";i:9;s:11:\"PEAKE, D. R\";i:10;s:9:\"REA, D. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:6:\"[S.n.]\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting\";s:9:\"\u0000*\u0000jtitle\";s:16:\"Oncology reports\";s:9:\"\u0000*\u0000stitle\";s:10:\"Oncol. rep\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"20\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"233\";s:8:\"\u0000*\u0000epage\";s:3:\"237\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1021-335X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HUSSAIN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:12:\"PALMER, D. H\";i:1;s:20:\"CHETIYAWARDANA, A. D\";i:2;s:12:\"CULLEN, M. H\";i:3;s:13:\"SWINSON, D. E\";i:4;s:8:\"RILEY, P\";i:5;s:8:\"WILLS, A\";i:6;s:8:\"BROWN, C\";i:7;s:11:\"DRAYCOTT, C\";i:8;s:11:\"EL-MODIR, A\";i:9;s:11:\"PEAKE, D. R\";i:10;s:9:\"REA, D. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:6:\"[S.n.]\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
